Maureen Privette

Background

About Maureen Privette

Background includes 27 years experience in the pharmaceutical industry both in drug development & clinical operations roles in all phases of drug development, Medical Affairs (post-marketing), Cardiovascular, Metabolic, GI, Immunology, Infectious Disease, Wyeth Infant Nutrition, Vaccines (COVID), Paxlovid & Rare Disease (Sickle -Cell, Hemophilia). Served in global leadership and/or support roles for multiple drug development teams (including strategy teams) and served as a Clinician/Clinical Scientist for programs leading to successful NDA submissions. Served in several clinical roles (safety, scientific, & operations) for global drug program leading to first global electronic dossier submission in industry history. Responsible for oversight of External Data Monitoring Committees. Served as a member of committee that designed and implemented institutional safety review council, served on pilot committee for in-licensing of clinical development software applications, and worked with Business Development group - supported clinical, business, related due diligence assessments and activities for therapeutic area in-licensing opportunities. BSN from Pennsylvania State University and is a registered nurse specialized in cardiac critical care (Main Line Health - Bryn Mawr Hospital).